UA97249C2 - Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors for inhibiting the growth of tumor cells - Google Patents
Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors for inhibiting the growth of tumor cellsInfo
- Publication number
- UA97249C2 UA97249C2 UAA200900388A UAA200900388A UA97249C2 UA 97249 C2 UA97249 C2 UA 97249C2 UA A200900388 A UAA200900388 A UA A200900388A UA A200900388 A UAA200900388 A UA A200900388A UA 97249 C2 UA97249 C2 UA 97249C2
- Authority
- UA
- Ukraine
- Prior art keywords
- class
- inhibiting
- growth
- inhibitors
- tumor cells
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention is concerned with combinations of a proteasome inhibitor and a histone deacetylase inhibitor with combined activity on class-I and class -IIB histone deacetylases, for inhibiting the growth of tumor cells, useful in the treatment of cancer.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06120726 | 2006-09-15 | ||
| PCT/EP2007/059518 WO2008031817A2 (en) | 2006-09-15 | 2007-09-11 | Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA97249C2 true UA97249C2 (en) | 2012-01-25 |
Family
ID=41040414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200900388A UA97249C2 (en) | 2006-09-15 | 2007-09-11 | Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors for inhibiting the growth of tumor cells |
Country Status (12)
| Country | Link |
|---|---|
| CN (1) | CN101516374B (en) |
| BR (1) | BRPI0716992A2 (en) |
| DK (1) | DK2066327T3 (en) |
| ES (1) | ES2399670T3 (en) |
| ME (1) | ME01514B (en) |
| NZ (1) | NZ575030A (en) |
| PT (1) | PT2066327E (en) |
| RS (1) | RS52638B (en) |
| SG (1) | SG177219A1 (en) |
| SI (1) | SI2066327T1 (en) |
| UA (1) | UA97249C2 (en) |
| ZA (1) | ZA200901818B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115028678A (en) * | 2022-07-08 | 2022-09-09 | 杭州医学院 | Bifunctional molecule based on BCR-ABL protein degradation induced by VHL ligand and preparation method and application thereof |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8957066B2 (en) * | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| CN107095871A (en) * | 2016-02-22 | 2017-08-29 | 中国科学院上海巴斯德研究所 | Quisinostat, a kind of new efficient antimalarial agent |
| WO2018017858A1 (en) * | 2016-07-20 | 2018-01-25 | The Trustees Of Columbia University In The City Of New York | Histone acetyltransferase activators and compositions and uses thereof |
| CN114409638B (en) * | 2022-02-09 | 2023-02-14 | 深圳大学 | Histone deacetylase 8 selective degradation agent, preparation method and application thereof in antitumor activity |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1781639B1 (en) * | 2004-07-28 | 2012-01-25 | Janssen Pharmaceutica NV | Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
-
2007
- 2007-09-11 SI SI200731143T patent/SI2066327T1/en unknown
- 2007-09-11 PT PT78033974T patent/PT2066327E/en unknown
- 2007-09-11 UA UAA200900388A patent/UA97249C2/en unknown
- 2007-09-11 RS RS20130038A patent/RS52638B/en unknown
- 2007-09-11 ME MEP-2013-15A patent/ME01514B/en unknown
- 2007-09-11 DK DK07803397.4T patent/DK2066327T3/en active
- 2007-09-11 SG SG2011092863A patent/SG177219A1/en unknown
- 2007-09-11 ES ES07803397T patent/ES2399670T3/en active Active
- 2007-09-11 CN CN200780034143.2A patent/CN101516374B/en active Active
- 2007-09-11 NZ NZ575030A patent/NZ575030A/en unknown
- 2007-09-11 BR BRPI0716992-2A2A patent/BRPI0716992A2/en not_active Application Discontinuation
-
2009
- 2009-03-13 ZA ZA200901818A patent/ZA200901818B/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115028678A (en) * | 2022-07-08 | 2022-09-09 | 杭州医学院 | Bifunctional molecule based on BCR-ABL protein degradation induced by VHL ligand and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| PT2066327E (en) | 2013-02-06 |
| NZ575030A (en) | 2012-07-27 |
| CN101516374B (en) | 2013-04-24 |
| ME01514B (en) | 2014-04-20 |
| SG177219A1 (en) | 2012-01-30 |
| ZA200901818B (en) | 2010-05-26 |
| SI2066327T1 (en) | 2013-04-30 |
| DK2066327T3 (en) | 2013-02-11 |
| CN101516374A (en) | 2009-08-26 |
| ES2399670T3 (en) | 2013-04-02 |
| BRPI0716992A2 (en) | 2013-09-17 |
| RS52638B (en) | 2013-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008031820A3 (en) | Combinations of class-i specific histone deacetylase inhibitors with proteasome inhibitors | |
| WO2008031817A3 (en) | Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors | |
| MX2009006542A (en) | Inhibitors of histone deacetylase and prodrugs thereof. | |
| MX2007011148A (en) | Histone deacetylase inhibitors sensitize cancer cells to epidermal growth factor inhibitors. | |
| EA201101053A1 (en) | PHOSPHYNOSIS INHIBITORS ITID-3-KINAZ WITH ZINC-BINDING GROUP | |
| MXPA06010900A (en) | Inhibitors of histone deacetylase. | |
| HK1087707A1 (en) | Inhibitors of histone deacetylase | |
| TW200734315A (en) | Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase | |
| WO2006060382A3 (en) | Use of hdac and/or dnmt inhibitors for treatment of ischemic injury | |
| EP2099443A4 (en) | Combination of er + ligands and histone deacetylase inhibitors for the treatment of cancer | |
| WO2006055621A3 (en) | Histone deacetylase inhibitors and methods of use | |
| MY183014A (en) | Compounds for enzyme inhibition | |
| HK1125359A1 (en) | N-sulphonylpyrroles and their use as histone deacetylase inhibitors n- | |
| MX349787B (en) | Oral dosage forms including an antiplatelet agent and an acid inhibitor. | |
| MX336994B (en) | Indolyl or indolinyl hydroxamate compounds. | |
| WO2008087643A3 (en) | Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors | |
| MX2009010485A (en) | Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors. | |
| UA97249C2 (en) | Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors for inhibiting the growth of tumor cells | |
| TN2012000205A1 (en) | Method and compositions for treating solid tumors and other malignancies | |
| WO2009076234A3 (en) | Synthesis methods of histone deacetylase inhibitors (hdacis) | |
| WO2008082646A3 (en) | Histone deacetylase inhibitors, combination therapies and methods of use | |
| MX2008008470A (en) | Novel pyrrole derivatives with histone deacetylase inhibitor activity. | |
| ZA200710497B (en) | Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders | |
| MX2011007373A (en) | Methods for identifying patients who will respond well to cancer treatment. | |
| WO2008140708A8 (en) | Use of hdac inhibitors for treatment of cardiac rhythm disorders |